This study reports the utility of the EpiXTM cell culture technology to expand airway epithelial cells from nasal brushing samples of CF patients for in vitro human cell-based models to test individual responses to CFTR-directed therapeutics. This evidence concerns the gene CFTR and cystic fibrosis.